|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.556
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.421
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.412
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.361
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.296
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.283
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.274
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.264
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.263
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.254
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.247
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.240
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.236
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.235
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.234
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.230
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.210
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.207
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.205
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.197
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.191
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.178
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.175
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.172
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.171
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.171
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.167
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.162
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.161
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.158
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.158
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.156
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.151
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.151
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.143
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.138
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.134
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.126
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.126
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.120
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.116
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.110
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.110
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.109
|
Human |
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.109
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.109
|
Mouse |
|
|
axonogenesis
|
GO:0007409 |
274 |
0.105
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.103
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.102
|
Mouse |
|
|
ossification
|
GO:0001503 |
216 |
0.101
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.100
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.100
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.099
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.099
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.098
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.096
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.095
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.094
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.092
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.091
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.090
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.089
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.089
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.088
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.086
|
Human |
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.085
|
|
|
|
pattern specification involved in metanephros development
|
GO:0072268 |
4 |
0.085
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.085
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.083
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.082
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.080
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.077
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.077
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.076
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.076
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.076
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.075
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.074
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.074
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.074
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.073
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.073
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.073
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.072
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.071
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.071
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.071
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.071
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.070
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.069
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.069
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.069
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.068
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.067
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.067
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.067
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.066
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.066
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.066
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.065
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.065
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.065
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.065
|
|
|
|
endochondral bone growth
|
GO:0003416 |
19 |
0.065
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.064
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.063
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.063
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.063
|
|
|
|
regulation of vascular wound healing
|
GO:0061043 |
2 |
0.063
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.062
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.061
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.061
|
|
|
|
pyramidal neuron migration
|
GO:0021852 |
1 |
0.061
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.060
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.059
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.059
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.059
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.059
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.059
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.058
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.058
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.058
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.058
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.058
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.057
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.056
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.056
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.056
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.056
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.056
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.056
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.055
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.055
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.055
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.055
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.054
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.054
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.054
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.054
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.054
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.053
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.053
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.052
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.052
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.052
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.051
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.051
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.050
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.050
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.050
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.050
|
|
|
|
regulation of eosinophil migration
|
GO:2000416 |
2 |
0.050
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.050
|
|
|
|
regulation of cell adhesion mediated by integrin
|
GO:0033628 |
13 |
0.050
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.050
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.049
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.049
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.049
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.049
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.048
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.048
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.048
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.047
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.047
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.047
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.047
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.046
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.046
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.046
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.046
|
Mouse |
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.046
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.046
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.046
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.045
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.045
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.045
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.045
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.045
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.044
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.044
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.044
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.044
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.044
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.043
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.043
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.043
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.043
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.042
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.042
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.042
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.042
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.042
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.041
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.041
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.041
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.041
|
|
|
|
positive regulation of eosinophil migration
|
GO:2000418 |
2 |
0.040
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.040
|
|
|
|
negative regulation of chemotaxis
|
GO:0050922 |
11 |
0.040
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.040
|
|
|
|
basement membrane organization
|
GO:0071711 |
8 |
0.039
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.039
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.038
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.038
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.038
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.038
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.038
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.038
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.038
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.038
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.038
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.037
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.037
|
Mouse |
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.037
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.036
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.036
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.036
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.036
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.036
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.035
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.035
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.035
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.035
|
|
|
|
positive regulation of thymocyte migration
|
GO:2000412 |
2 |
0.035
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.035
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.035
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.035
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.035
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.035
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.035
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.034
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.034
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.034
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.034
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.034
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.034
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.034
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.033
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.033
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.033
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.032
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.032
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.032
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.032
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.032
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.032
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.032
|
|
|
|
renal capsule development
|
GO:0072127 |
1 |
0.032
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.032
|
|
|
|
regulation of thymocyte migration
|
GO:2000410 |
2 |
0.031
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.031
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.031
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.031
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.031
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.031
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.031
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.031
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.031
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.031
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.031
|
|
|
|
metanephric capsule specification
|
GO:0072267 |
1 |
0.031
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.030
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.030
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.030
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.030
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.029
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.029
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.029
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.029
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.029
|
|
|
|
vascular wound healing
|
GO:0061042 |
3 |
0.029
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.029
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.029
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.029
|
Mouse |
|
|
cerebral cortex radially oriented cell migration
|
GO:0021799 |
31 |
0.029
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.028
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.028
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.028
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.028
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.028
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.028
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.028
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.028
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.028
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.028
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.028
|
|
|
|
metanephric capsule morphogenesis
|
GO:0072265 |
1 |
0.028
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.028
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.028
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.028
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.027
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.027
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.027
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.027
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.027
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.027
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.027
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.027
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.027
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.027
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.027
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.027
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.026
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.026
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.026
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.026
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.026
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.026
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.026
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.026
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.026
|
|
|
|
positive regulation of transcription from rna polymerase iii promoter
|
GO:0045945 |
1 |
0.026
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.025
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.025
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.025
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.025
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.025
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.025
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.025
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.025
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.025
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.025
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.025
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.025
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.025
|
|
|
|
detection of glucose
|
GO:0051594 |
1 |
0.025
|
|
|
|
negative regulation of glucokinase activity
|
GO:0033132 |
4 |
0.024
|
|
|
|
positive regulation of smoothened signaling pathway
|
GO:0045880 |
23 |
0.024
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.024
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902043 |
13 |
0.024
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.024
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.024
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.024
|
|
|
|
positive regulation of transcription by glucose
|
GO:0046016 |
3 |
0.024
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.024
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.024
|
|
|
|
glycosaminoglycan metabolic process
|
GO:0030203 |
34 |
0.024
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.024
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.024
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.024
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.024
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.024
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.024
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.023
|
|
|
|
thymocyte migration
|
GO:0072679 |
2 |
0.023
|
|
|
|
metanephric capsule development
|
GO:0072213 |
1 |
0.023
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.023
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.023
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.023
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.023
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.023
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.023
|
|
|
|
epithelial cell differentiation involved in mammary gland alveolus development
|
GO:0061030 |
4 |
0.023
|
|
|
|
cell adhesion mediated by integrin
|
GO:0033627 |
18 |
0.023
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.023
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.023
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.023
|
Mouse |
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.023
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.023
|
|
|
|
inflammatory response to wounding
|
GO:0090594 |
4 |
0.023
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.022
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.022
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.022
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.022
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.022
|
|
|
|
neuron neuron synaptic transmission
|
GO:0007270 |
69 |
0.022
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.022
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.022
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.022
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.021
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.021
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.021
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.021
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.021
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.021
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.021
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.021
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.021
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.021
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.021
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.021
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.021
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.021
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.021
|
|
|
|
renal capsule formation
|
GO:0072129 |
1 |
0.021
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.021
|
|
|
|
regulation of cell migration involved in sprouting angiogenesis
|
GO:0090049 |
4 |
0.021
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.021
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.021
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.021
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.021
|
|
|
|
maternal placenta development
|
GO:0001893 |
20 |
0.021
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.021
|
|
|
|
wnt signaling pathway involved in somitogenesis
|
GO:0090244 |
4 |
0.021
|
|
|
|
carbon catabolite repression of transcription
|
GO:0045013 |
1 |
0.021
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.021
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.020
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.020
|
|
|
|
positive regulation of alpha beta t cell differentiation
|
GO:0046638 |
28 |
0.020
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.020
|
|
|
|
somatic sex determination
|
GO:0018993 |
2 |
0.020
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.020
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.020
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.020
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.020
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.020
|
|
|
|
prostate gland stromal morphogenesis
|
GO:0060741 |
2 |
0.020
|
|
|
|
growth plate cartilage development
|
GO:0003417 |
14 |
0.020
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.020
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.020
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.020
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.020
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.020
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.020
|
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
0 |
0.020
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.020
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.019
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.019
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.019
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.019
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.019
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.019
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.019
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.019
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.019
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.019
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.019
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.019
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.019
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.019
|
|
|
|
glomerular endothelium development
|
GO:0072011 |
2 |
0.019
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.019
|
|
|
|
cellular response to bmp stimulus
|
GO:0071773 |
14 |
0.019
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.019
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.019
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.019
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.019
|
|
|
|
positive regulation of t helper 1 cell differentiation
|
GO:0045627 |
4 |
0.019
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.019
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.019
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.019
|
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.019
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.018
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.018
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.018
|
|
|
|
aminoglycan metabolic process
|
GO:0006022 |
34 |
0.018
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
41 |
0.018
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.018
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.018
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.018
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
45 |
0.018
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.018
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.018
|
|
|
|
negative regulation of cellular carbohydrate metabolic process
|
GO:0010677 |
19 |
0.018
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.018
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.018
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.018
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.018
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.018
|
|
|
|
female sex determination
|
GO:0030237 |
1 |
0.018
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.018
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.018
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000433 |
1 |
0.018
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.018
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.017
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.017
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.017
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.017
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.017
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.017
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.017
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.017
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.017
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.017
|
|
|
|
astrocyte cell migration
|
GO:0043615 |
3 |
0.017
|
|
|
|
negative regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902257 |
2 |
0.017
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.017
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.017
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.017
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
40 |
0.017
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.017
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.017
|
|
|
|
negative regulation of hexokinase activity
|
GO:1903300 |
4 |
0.017
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.017
|
|
|
|
carbon catabolite regulation of transcription
|
GO:0045990 |
4 |
0.017
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.017
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.017
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.016
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.016
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.016
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.016
|
|
